Home/ Stocks/ BIOA

BioAge Labs, Inc. Common Stock

BIOA XNAS

$11.72 +0.43 (+3.82%) ▲ 15-min delayed

Open

$11.40

High

$11.94

Low

$11.23

Volume

953.4K

Market Cap

$517.26M

About BioAge Labs, Inc. Common Stock

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 62 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$2.45M	$-26,097,000	$-0.58
Q1 2026	$2.77M	$-22,253,000	$-0.52
FY 2025	$8.99M	$-80,605,000	$-2.24
Q3 2025	$2.05M	$-20,171,000	$-0.56

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for BIOA yet. Check out our latest market news or earnings calendar.

Get BIOA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on BioAge Labs, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.